Cargando…

Exogenous pulmonary surfactant for acute respiratory distress syndrome in adults: A systematic review and meta-analysis

Acute respiratory distress syndrome (ARDS) is often characterized by reduced lung compliance, which suggests dysfunction of the endogenous surfactant system. The effectiveness of exogenous surfactants as replacements for the endogenous system in the treatment of ARDS in adults was assessed. Randomiz...

Descripción completa

Detalles Bibliográficos
Autores principales:	ZHANG, LI-NA, SUN, JUN-PING, XUE, XIN-YING, WANG, JIAN-XIN
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524286/ https://www.ncbi.nlm.nih.gov/pubmed/23251275 http://dx.doi.org/10.3892/etm.2012.746

Ejemplares similares

Exogenous pulmonary surfactant for the treatment of adult patients with acute respiratory distress syndrome: results of a meta-analysis
por: Davidson, Warren J, et al.
Publicado: (2006)

Exogenous surfactant therapy for acute respiratory distress in infancy
por: Moreno, M., et al.
Publicado: (1996)

Effect of different ventilation methods combined with pulmonary surfactant on neonatal acute respiratory distress syndrome
por: Qing, Qing, et al.
Publicado: (2023)

Exogenous Surfactant May Improve Oxygenation but Not Mortality in Adult Patients with Acute Lung Injury/Acute Respiratory Distress Syndrome: A Meta-Analysis of 9 Clinical Trials
por: Meng, Haoyu, et al.
Publicado: (2012)

Use of exogenous pulmonary surfactant in acute respiratory distress syndrome (ARDS): Role in SARS-CoV-2-related lung injury
por: Cattel, Francesco, et al.
Publicado: (2021)

Efficacy of exogenous surfactant in adult patients with acute respiratory failure
por: Tiruvoipati, R, et al.
Publicado: (2006)

Exogenous Surfactant Therapy in Acute Lung Injury/Acute Respiratory Distress Syndrome: The Need for a Revised Paradigm Approach
por: Dushianthan, Ahilanandan, et al.
Publicado: (2012)

The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19
por: Wang, Shengguang, et al.
Publicado: (2021)

Surfactant alteration and replacement in acute respiratory distress syndrome
por: Günther, Andreas, et al.
Publicado: (2001)

Lung ultrasound to guide the administration of exogenous pulmonary surfactant in respiratory distress syndrome of newborn infants: A retrospective investigation study
por: Liu, Jing, et al.
Publicado: (2022)

The Role of Surfactant in Respiratory Distress Syndrome
por: Ma, Christopher Cheng-Hwa, et al.
Publicado: (2012)

Effect of low-dose exogenous surfactant on infants with acute respiratory distress syndrome after cardiac surgery: a retrospective analysis
por: Zhang, Rongyuan, et al.
Publicado: (2020)

Pulmonary surfactant combined with budesonide in the treatment of neonatal respiratory distress syndrome
por: Guo, Hongxing, et al.
Publicado: (2023)

Clinical review: Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome - where do we go from here?
por: Dushianthan, Ahilanandan, et al.
Publicado: (2012)

Effect of surfactant administration on outcomes of adult patients in acute respiratory distress syndrome: a meta-analysis of randomized controlled trials
por: Meng, Shan-Shan, et al.
Publicado: (2019)

History of Pulmonary Surfactant Replacement Therapy for Neonatal Respiratory Distress Syndrome in Korea
por: Bae, Chong-Woo, et al.
Publicado: (2019)

Profound Effect of Pulmonary Surfactant on the Treatment of Preterm Infants with Respiratory Distress Syndrome
por: Liu, Lin, et al.
Publicado: (2022)

Pulmonary surfactant function in patients with acute lung injury/acute respiratory distress syndrome treated by mechanical ventilation
por: Miller, E, et al.
Publicado: (2005)

Effects of Xuanbai Chengqi decoction on lung compliance for patients with exogenous pulmonary acute respiratory distress syndrome
por: Mao, Zhengrong, et al.
Publicado: (2016)

Efficacy of pulmonary surfactant combined with high-dose ambroxol hydrochloride in the treatment of neonatal respiratory distress syndrome
por: Xiang, Jiajun, et al.
Publicado: (2019)

Comparative efficacy of pulmonary surfactant in respiratory distress syndrome in preterm infants: a Bayesian network meta-analysis
por: Qiu, Caihong, et al.
Publicado: (2020)

Lung Mechanics in COVID-19 Resemble Respiratory Distress Syndrome, Not Acute Respiratory Distress Syndrome: Could Surfactant Be a Treatment?
por: Koumbourlis, Anastassios C., et al.
Publicado: (2020)

Aerosolized Surfactant for Preterm Infants with Respiratory Distress Syndrome
por: Brasher, Mandy, et al.
Publicado: (2021)

Time-dependent changes in pulmonary surfactant function and composition in acute respiratory distress syndrome due to pneumonia or aspiration
por: Schmidt, Reinhold, et al.
Publicado: (2007)

Efficacy study of pulmonary surfactant combined with assisted ventilation for acute respiratory distress syndrome management of term neonates
por: Liu, Jinfeng, et al.
Publicado: (2017)

Surfactants in Acute Respiratory Distress Syndrome in Infants and Children: Past, Present and Future
por: Amigoni, Angela, et al.
Publicado: (2017)

Surfactant replacement therapy in acute respiratory distress syndrome from viral pneumonia
por: Putz, G., et al.
Publicado: (1996)

Alveolar surfactant and adult respiratory distress syndrome: Pathogenetic role and therapeutic prospects
por: Seeger, W., et al.
Publicado: (1993)

The effect of high-frequency oscillatory ventilator combined with pulmonary surfactant in the treatment of neonatal respiratory distress syndrome
por: Wang, Tie-Yan, et al.
Publicado: (2022)

The Use of Exogenous Lung Surfactant (Poractant Alfa) in Acute Respiratory Failure by Drowning
por: Pezzi, Mario, et al.
Publicado: (2020)

Continuous positive pressure ventilation combined with pulmonary surfactant in the treatment of neonatal respiratory distress syndrome
por: Miao, Jing, et al.
Publicado: (2020)

Dry powder nebulization of a recombinant surfactant protein C-based surfactant for treatment of acute respiratory distress syndrome
por: Ruppert, C, et al.
Publicado: (2007)

Altered molecular specificity of surfactant phosphatidycholine synthesis in patients with acute respiratory distress syndrome
por: Dushianthan, Ahilanandan, et al.
Publicado: (2014)

Breath-Synchronized Nebulized Surfactant in a Porcine Model of Acute Respiratory Distress Syndrome
por: DiBlasi, Robert M., et al.
Publicado: (2021)

Trial of aerosolised surfactant for preterm infants with respiratory distress syndrome
por: Jardine, Luke, et al.
Publicado: (2022)

Nebulized versus invasively delivered surfactant therapy for neonatal respiratory distress syndrome: A systematic review and meta-analysis
por: Rong, Hui, et al.
Publicado: (2020)

“Obesity Paradox” in Acute Respiratory Distress Syndrome: Asystematic Review and Meta-Analysis
por: Zhi, Guo, et al.
Publicado: (2016)

Alveolar epithelial glycocalyx degradation mediates surfactant dysfunction and contributes to acute respiratory distress syndrome
por: Rizzo, Alicia N., et al.
Publicado: (2022)

Pharmacotherapy for Adult Patients with Acute Respiratory Distress Syndrome
por: Yin, Jun, et al.
Publicado: (2018)

Exogenous Pulmonary Surfactant as a Vehicle for Antimicrobials: Assessment of Surfactant-Antibacterial Interactions In Vitro
por: Birkun, Alexei
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4ubm2kmjaop3t616ofplmrv3jm